Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-06 Purchase | 2024-03-08 11:24 am | Perspective Therapeutics Inc. | CATX | Lantheus Alpha Therapy LLC Lantheus Holdings Inc. 10% Owner | 60,431,039 | $0.95 | $57,409,487 | 116,773,394 (Direct) | View |
| 2024-01-30 Purchase | 2024-02-01 4:53 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 127,206 | $0.7131 | $90,710 | 342,424 (Indirect Direct) | View |
| 2024-01-26 Purchase | 2024-01-30 4:57 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 135,879 | $0.57753 | $78,474 | 215,218 (Indirect Direct) | View |
| 2024-01-24 Purchase | 2024-01-26 5:40 pm | Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer | 280,000 | $0.4996 | $139,888 | 1,375,425 (Direct) | View |
| 2024-01-24 Purchase | 2024-01-26 5:38 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 51,996 | $0.49 | $25,478 | 79,339 (Indirect Direct) | View |
| 2023-12-21 Purchase | 2023-12-26 5:00 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 3,663 | $0.3283 | $1,203 | 27,343 (Indirect Direct) | View |
| 2023-12-18 Purchase | 2023-12-19 7:11 pm | Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer | 125,000 | $0.2587 | $32,338 | 316,710 (Direct) | View |
| 2023-12-18 Purchase | 2023-12-19 7:10 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 23,680 | $0.29466 | $6,978 | 23,680 (Direct) | View |
| 2023-12-15 Purchase | 2023-12-19 7:09 pm | Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer | 595,425 | $0.31698 | $188,737 | 1,095,425 (Direct) | View |
| 2023-12-14 Purchase | 2023-12-18 4:16 pm | Perspective Therapeutics Inc. | CATX | Woods Lori A Director | 185,200 | $0.26992 | $49,989 | 1,567,814 (Indirect Direct) | View |
| 2022-12-01 Purchase | 2022-12-05 6:09 pm | Isoray Inc. | ISR | Hunt Jonathan Robert Chief Financial Officer | 85,404 | $0.38056 | $32,501 | 191,710 (Direct) | View |
| 2022-11-15 Purchase | 2022-11-17 6:43 pm | Isoray Inc. | ISR | Woods Lori A CEO | 100,000 | $0.3354 | $33,540 | 1,195,114 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-23 Exercise | 2024-04-24 4:35 pm | N/A 2032-08-09 | Perspective Therapeutics Inc. | CATX | Austin Mark John VP Finance/Prin Fin&Acct Offic | 30,000 | $0 | 204,030 (Direct) | View |
| 2024-04-23 Exercise | 2024-04-24 4:35 pm | N/A N/A | Perspective Therapeutics Inc. | CATX | Austin Mark John VP Finance/Prin Fin&Acct Offic | 30,000 | $0.36 | 204,030 (Direct) | View |
Ownership | 2024-02-01 07:56 am | N/A N/A | Perspective Therapeutics Inc. | CATX | Lantheus Alpha Therapy LLC Lantheus Holdings Inc. 10% Owner | 0 | $0 | 56,342,355 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:44 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer | 1,477,619 | $0 | 2,885,688 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:42 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO | 3,338,878 | $0 | 11,793,635 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:36 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer | 1,248,776 | $0 | 2,527,429 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:34 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | Morich Frank Director | 230,000 | $0 | 2,037,471 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:32 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 230,000 | $0 | 930,000 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:30 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director | 230,000 | $0 | 930,000 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:28 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | Woods Lori A Director | 230,000 | $0 | 2,412,500 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 4:47 pm | N/A 2033-06-12 | Perspective Therapeutics Inc. | CATX | Streeter Jennifer COO & VP of HR | 500,000 | $0 | 1,722,500 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 4:45 pm | N/A 2033-06-12 | Perspective Therapeutics Inc. | CATX | Austin Mark John VP Finance/Prin Fin&Acct Offic | 225,000 | $0 | 773,115 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 4:34 pm | N/A 2033-06-02 | Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director | 700,000 | $0 | 1,170,000 (Direct) | View |
| 2023-04-13 Exercise | 2023-04-19 5:52 pm | N/A N/A | Perspective Therapeutics Inc. | ISR | Woods Lori A Director | 187,500 | $0.61 | 1,382,614 (Indirect) | View |
| 2023-04-13 Exercise | 2023-04-19 5:52 pm | N/A 2030-06-23 | Perspective Therapeutics Inc. | ISR | Woods Lori A Director | 187,500 | $0 | 1,382,614 (Direct) | View |
| 2023-02-21 Option Award | 2023-03-17 5:10 pm | N/A 2033-02-21 | Perspective Therapeutics Inc. | ISR | Williamson Robert F III Director | 700,000 | $0 | 1,170,000 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-23 7:35 pm | N/A 2033-02-21 | Perspective Therapeutics Inc. | ISR | Morich Frank Director | 700,000 | $0 | 3,384,942 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-23 7:33 pm | N/A 2033-02-21 | Perspective Therapeutics Inc. | ISR | Woods Lori A Director | 700,000 | $0 | 4,510,000 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-23 7:32 pm | N/A 2033-02-21 | Perspective Therapeutics Inc. | ISR | McCormick Michael W Director | 700,000 | $0 | 2,019,230 (Direct) | View |
Ownership | 2023-02-13 4:33 pm | N/A 2031-02-28 | Isoray Inc. | ISR | Morich Frank Director | 0 | $0 | 1,107,471 (Direct) | View |
Ownership | 2023-02-13 4:32 pm | N/A N/A | Isoray Inc. | ISR | Puhlmann Markus Chief Medical Officer | 0 | $0 | 1,908,069 (Direct) | View |
Ownership | 2023-02-13 4:30 pm | N/A N/A | Isoray Inc. | ISR | Spoor Johan M. CEO | 0 | $0 | 8,562,329 (Direct) | View |
| 2022-08-18 Exercise(A) | 2022-09-22 5:05 pm | N/A N/A | Isoray Inc. | ISR | Streeter Jennifer COO & VP of HR | 50,000 | $0.43 | 77,940 (Direct) | View |
| 2022-08-18 Exercise(A) | 2022-09-22 5:05 pm | N/A 2029-06-18 | Isoray Inc. | ISR | Streeter Jennifer COO & VP of HR | 50,000 | $0 | 77,940 (Direct) | View |
| 2022-08-18 Exercise | 2022-08-19 6:26 pm | N/A N/A | Isoray Inc. | ISR | Streeter Jennifer COO & VP of HR | 50,000 | $0.43 | 87,940 (Direct) | View |
| 2022-08-18 Exercise | 2022-08-19 6:26 pm | N/A 2029-06-18 | Isoray Inc. | ISR | Streeter Jennifer COO & VP of HR | 50,000 | $0 | 87,940 (Direct) | View |
| 2022-08-09 Option Award | 2022-08-11 7:04 pm | N/A 2032-08-09 | Isoray Inc. | ISR | Austin Mark John VP Finance/Prin Fin&Acct Offic | 150,000 | $0 | 548,115 (Direct) | View |
| 2022-08-05 Exercise | 2022-08-10 8:14 pm | N/A N/A | Isoray Inc. | ISR | Streeter Jennifer COO & VP of HR | 22,500 | $0.33 | 27,940 (Direct) | View |
| 2022-08-05 Exercise | 2022-08-10 8:14 pm | N/A 2032-07-21 | Isoray Inc. | ISR | Streeter Jennifer COO & VP of HR | 22,500 | $0 | 27,940 (Direct) | View |
| 2022-07-21 Option Award | 2022-08-01 7:18 pm | N/A 2032-07-21 | Isoray Inc. | ISR | Cavanagh William Chief R&D Officer | 475,000 | $0 | 1,493,846 (Direct) | View |
| 2022-07-21 Option Award | 2022-07-29 6:28 pm | N/A 2032-07-21 | Isoray Inc. | ISR | McCormick Michael W Director | 135,000 | $0 | 424,615 (Direct) | View |